SAGE has developed a highly effective approach to identify the best treatment for cancer patients that overcomes the inherent limitations of genomic testing. This is accomplished by creating 3D microtumor replicates from a fresh tissue biopsy that reflect the patient tumor's heterogeneity and extracellular matrix.